Technetium ion (specifically, Technetium-99 ion(4+), also known as Tc^4+ or Tc-99 ion[5]) (Tc^4+)

Technetium ion is a form of the synthetic radioactive transition metal technetium, typically encountered in the oxidation state +4 (Tc^4+) or +7 in chemical compounds. Technetium ions are integral to radiopharmaceutical preparations, most notably technetium-99m-labeled compounds, which are used worldwide for medical diagnostic imaging due to technetium-99m's favorable nuclear properties (short half-life, gamma emission). The ion itself is not a therapeutic target and has no intrinsic biological function; its primary use is as a tracer or label in complexes specially designed to bind specific tissues or organs for imaging[5][6][2][3]. The chemistry of technetium ions is complex, with multiple oxidation states and compound types, making them versatile in radiopharmacy but not individually relevant as a molecular target for pharmaceutical intervention[7]. Summary of issue: “Technetium ion” is a chemical ion/element, not a molecular or cellular target suitable for therapeutic intervention. Its use in medicine is in the context of radioactive tracer agents (e.g., Tc-99m complexes for imaging), not drug targeting or molecular modulation. For structured target data, technetium ion is generally classified under “Other,” and should *not* be considered a classical target like receptors or enzymes. If radiopharmaceuticals or their physiological binding motifs (e.g., particular receptors or enzymes targeted by technetium-labeled ligands) are the real intended targets, those should be specified instead.

Other names

Technetium(IV) ionTc^4+Technetium-99 ion(4+)O8ZBE8ML98UNII-O8ZBE8ML98Tc-99 ion